XML 42 R29.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Mergers and Acquisitions (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2015
ActoGeniX NV |
Business Acquisition [Line Items] |
Acquisition Date Fair Value Consideration Transferred | The fair value of the total consideration transferred was $72,474. The acquisition date fair value of each class of consideration transferred is presented below:
Cash | $ | 32,739 |
Common shares | 39,735 |
| $ | 72,474 |
Estimated Fair Value of Assets Acquired and Liabilities Assumed at Acquisition Date | The preliminary estimated fair value of assets acquired and liabilities assumed at the acquisition date is shown below:
Cash | $ | 3,180 |
Other receivables | 305 |
Prepaid expenses and other | 31 |
Property, plant and equipment | 209 |
Intangible assets | 68,100 |
Other assets | 23 |
Total assets acquired | 71,848 |
Accounts payable | 230 |
Accrued compensation and benefits | 624 |
Other accrued liabilities | 307 |
Deferred revenue | 732 |
Deferred tax liability | 612 |
Total liabilities assumed | 2,505 |
Net assets acquired | 69,343 |
Goodwill | 3,131 |
Total consideration | $ | 72,474 |
Medistem, Inc. |
Business Acquisition [Line Items] |
Acquisition Date Fair Value Consideration Transferred | The fair value of the total consideration transferred was $24,995. The acquisition date fair value of each class of consideration transferred is presented below:
Cash | $ | 4,920 |
Common shares | 19,368 |
Settlement of promissory notes | 707 |
| $ | 24,995 |
Estimated Fair Value of Assets Acquired and Liabilities Assumed at Acquisition Date | The estimated fair value of assets acquired and liabilities assumed at the acquisition date is shown in the table below.
Cash | $ | 8 |
Intangible assets | 4,824 |
Total assets acquired | 4,832 |
Accounts payable | 644 |
Accrued compensation and benefits | 67 |
Other accrued expenses | 50 |
Total liabilities assumed | 761 |
Net assets acquired | 4,071 |
Goodwill | 20,924 |
Total consideration | $ | 24,995 |
Trans Ova Genetics, LC |
Business Acquisition [Line Items] |
Acquisition Date Fair Value Consideration Transferred | The fair value of the total consideration transferred, including the noncontrolling interest in a majority-owned subsidiary of Trans Ova, was $127,875. The acquisition date fair value of each class of consideration transferred and noncontrolling interest is presented below:
Cash | $ | 63,625 |
Common shares | 32,802 |
Deferred cash consideration | 20,115 |
Total consideration transferred | 116,542 |
Fair value of noncontrolling interest | 11,333 |
Total | $ | 127,875 |
Estimated Fair Value of Assets Acquired and Liabilities Assumed at Acquisition Date | The estimated fair value of assets acquired and liabilities assumed at the acquisition date is shown in the table below.
Cash | $ | 960 |
Trade receivables | 18,693 |
Related party receivables | 1,219 |
Inventory | 18,476 |
Prepaid expenses and other | 590 |
Property, plant and equipment | 21,164 |
Intangible assets | 23,700 |
Other assets | 147 |
Total assets acquired | 84,949 |
Accounts payable | 3,317 |
Accrued compensation and benefits | 913 |
Other accrued liabilities | 271 |
Deferred revenue | 4,458 |
Lines of credit | 4,091 |
Related party payables | 1,246 |
Long term debt | 9,090 |
Total liabilities assumed | 23,386 |
Net assets acquired | 61,563 |
Goodwill | 66,312 |
Total consideration and fair value of noncontrolling interest | $ | 127,875 |
2015 Business Acquisitions |
Business Acquisition [Line Items] |
Condensed Pro forma Financial Information | The following unaudited condensed pro forma financial information for the three months ended March 31, 2015 and 2014 is presented as if the acquisition had been consummated on January 1, 2014:
| Three Months Ended March 31,
| 2015 |  | 2014
| Pro forma
Revenues | $ | 33,927 |  |  | $ | 7,854 |
Income before income taxes | 23,282 |  |  | 1,582 |
Net Income | 22,487 |  |  | 1,276 |
Net loss attributable to the noncontrolling interests | 1,293 |  |  | 866 |
Net income attributable to Intrexon | 23,780 |  |  | 2,142 |
2014 Business Acquisitions |
Business Acquisition [Line Items] |
Condensed Pro forma Financial Information | The following unaudited condensed pro forma financial information for the three months ended March 31, 2014 is presented as if the acquisitions had been consummated on January 1, 2013:
| Three Months Ended March 31, 2014
| Pro forma
Revenues | $ | 22,211 |
Income before income taxes | 1,319 |
Net income | 1,013 |
Net income attributable to the noncontrolling interests | 976 |
Net income attributable to Intrexon | 1,989 |

X
- Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463 + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_A2014BusinessAcquisitionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_A2015BusinessAcquisitionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_ActoGeniXNVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_MedistemIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=xon_TransOvaGeneticsLcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |